Pathway AI

Account ⋅ Sign Out

Table of contents

Relapsing polychondritis

Key sources
The following summarized guidelines for the evaluation and management of relapsing polychondritis are prepared by our editorial team based on guidelines from the American College of Rheumatology (ACR 2023), the European League Against Rheumatism (EULAR 2022), and the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET 2018).


1.Diagnostic investigations

Pretreatment evaluation: screen for HBV infection in all patients eligible for treatment with conventional synthetic, biological, or targeted synthetic DMARDs, immunosuppressants, or corticosteroids (according to dose and duration).
Show 3 more
Create free account

2.Medical management

General principles: take into account disease severity and patient individual characteristics to decide on the treatment strategy in patients with RP, and contact an RP center when appropriate.

More topics in this section

  • Management of auricular or nasal chondritis

  • Management of peristernal chondritis

  • Management of tracheal chondritis

  • Management of articular involvement

  • Management of cutaneous involvement

  • Management of cardiac involvement

  • Management of ocular involvement

  • Management of audiovestibular involvement

  • Management of nervous system involvement

  • Management of renal involvement

3.Preventative measures

Routine immunizations: consider offering high-dose or adjuvanted influenza vaccination, rather than regular-dose influenza vaccination, in ≥ 65 years old patients with rheumatic or musculoskeletal diseases and in 18-65 years old patients with rheumatic or musculoskeletal diseases on immunosuppressive medications.
Show 17 more

More topics in this section

  • Prophylaxis for P. jirovecii pneumonia